Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 18 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Bit error mitigation
Internal wiring structure of semiconductor device
Integrated circuit packaging system with coupling features and method of manufacture thereof
RPM Controlled Wind Power Generation System
Writing implement
Method and system for delivering and executing virtual container on logical partition of target computing device
  Randomly Featured Patents
Motorcycle muffler guard
Micro-beam tactile sensor for the measurement of vertical position displacement
Endo-xyloglucan transferase
Display pager
Correlation circuit for spread spectrum communication, demodulation circuit and reception apparatus
Scrim reinforced, flat cloth-like composite laminate and a method of making
Method and apparatus for automatic savings upon event detection
Garden ball
Process for extruding large oriented polymer shapes
Systems and methods for positioning fluid supply system